Masaki Kato
Masaki Kato
Associate Professor, Department of Neuropsychiatry, Kansai Medical University
Verified email at takii.kmu.ac.jp
TitleCited byYear
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
A Serretti, M Kato, D De Ronchi, T Kinoshita
Molecular psychiatry 12 (3), 247, 2007
5082007
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M Kato, A Serretti
Molecular psychiatry 15 (5), 473, 2010
4242010
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
M Kato, T Fukuda, A Serretti, M Wakeno, G Okugawa, Y Ikenaga, Y Hosoi, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2), 398-404, 2008
1592008
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese …
M Kato, T Fukuda, M Wakeno, K Fukuda, G Okugawa, Y Ikenaga, ...
Neuropsychobiology 53 (4), 186-195, 2006
1372006
Effect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder
M Kato, T Fukuda, M Wakeno, G Okugawa, Y Takekita, S Watanabe, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009
932009
Pharmacogenetic studies in depression: a proposal for methodologic guidelines
A Serretti, M Kato, JL Kennedy
The pharmacogenomics journal 8 (2), 90, 2008
852008
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism
M Kato, Y Ikenaga, M Wakeno, G Okugawa, K Nobuhara, T Fukuda, ...
International clinical psychopharmacology 20 (3), 151-156, 2005
842005
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
JM Biernacka, K Sangkuhl, G Jenkins, RM Whaley, P Barman, A Batzler, ...
Translational psychiatry 5 (4), e553, 2015
792015
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence
C Han, SM Wang, M Kato, SJ Lee, AA Patkar, PS Masand, CU Pae
Expert review of neurotherapeutics 13 (7), 851-870, 2013
622013
Differences in quantitative EEG between frontotemporal dementia and Alzheimer’s disease as revealed by LORETA
K Nishida, M Yoshimura, T Isotani, T Yoshida, Y Kitaura, A Saito, H Mii, ...
Clinical Neurophysiology 122 (9), 1718-1725, 2011
402011
Augmentation treatments with second-generation antipsychotics to antidepressants in treatment-resistant depression
M Kato, CM Chang
CNS drugs 27 (1), 11-19, 2013
372013
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
M Wakeno, M Kato, G Okugawa, T Fukuda, Y Hosoi, Y Takekita, ...
Journal of clinical psychopharmacology 28 (5), 518-524, 2008
352008
The serotonin transporter gene and effectiveness of SSRIs
A Serretti, M Kato
Expert review of neurotherapeutics 8 (1), 111-120, 2008
342008
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression
M Kato, M Wakeno, G Okugawa, T Fukuda, J Azuma, T Kinoshita, ...
Neuropsychobiology 56 (4), 167-171, 2007
342007
Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients
M Kato, M Wakeno, G Okugawa, T Fukuda, Y Takekita, Y Hosoi, J Azuma, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (4), 1041-1044, 2008
332008
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients
M Kato, R Zanardi, D Rossini, D De Ronchi, G Okugawa, T Kinoshita, ...
Psychiatry research 167 (1-2), 97-105, 2009
302009
Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
M Kato, G Okugawa, M Wakeno, Y Takekita, S Nonen, S Tetsuo, ...
European neuropsychopharmacology 19 (10), 718-725, 2009
282009
Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression
K Kurose, K Hiratsuka, K Ishiwata, J Nishikawa, S Nonen, J Azuma, ...
Psychiatry research 198 (3), 424-429, 2012
232012
Estimated cognitive decline in patients with schizophrenia: a multicenter study
H Fujino, C Sumiyoshi, Y Yasuda, H Yamamori, M Fujimoto, M Fukunaga, ...
Psychiatry and clinical neurosciences 71 (5), 294-300, 2017
202017
Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials
Y Takekita, T Suwa, N Sunada, H Kawashima, C Fabbri, M Kato, A Tajika, ...
European archives of psychiatry and clinical neuroscience 266 (8), 703-717, 2016
162016
The system can't perform the operation now. Try again later.
Articles 1–20